tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Revenue

Compare
0 Followers

Oncolys BioPharma, Inc. Revenue

Oncolys BioPharma, Inc. had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 31.38M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Oncolys BioPharma, Inc. had annual revenue of 31.38M with -50.21% growth.
Revenue (ttm)
31.38M
Revenue Growth
11.93%
P/S Ratio
486.84
Revenue/Employee
¥784,600
Employees
40
Market Cap
¥15.28B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
31.38M-31.65M-50.21%
Dec 31, 2023
63.04M-913.14M-93.54%
Dec 31, 2022
976.18M333.69M+51.94%
Dec 31, 2021
642.49M328.31M+104.50%
Dec 31, 2020
314.18M-989.66M-75.90%
Dec 31, 2019
1.30B1.14B+673.57%
Dec 31, 2018
168.55M-60.59M-26.44%
Dec 31, 2017
229.14M50.83M+28.50%
Dec 31, 2016
178.31M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis